| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Common Stock | -Disposed to Issuer | -$493,326 | -3,981 | -2.49% | $123.92 | 156,187 | Dec 27, 2023 | Direct | |
| transaction | EOG | Common Stock | -Tax liability | -$100,003 | -807 | -0.52% | $123.92 | 155,380 | Dec 27, 2023 | Direct | |
| transaction | EOG | Common Stock | +Options Exercise | $493,314 | +6,030 | +3.91% | $81.81 | 160,168 | Dec 27, 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EOG | Stock Appreciation Rights | -Options Exercise | $0 | -6,030 | -49.92% | $0.00 | 6,049 | Dec 27, 2023 | Common Stock | 6,030 | $81.81 | Direct | F1 |
| Id | Content |
|---|---|
| F1 | The SARs granted become exercisable in increments of 33.3%, 33.3% and 33.4% on each of the first three anniversaries, respectively, of the September 27, 2021 date of grant. The SARs granted will become fully exercisable on September 27, 2024. This exercise did not involve any open-market sale of the Issuer's Common Stock. |